Why these 4 ASX shares have tumbled lower today

In afternoon trade the S&P/ASX 200 (Index: ^AXJO) (ASX: XJO) has dropped lower despite solid gains from resources shares. At the time of writing the index is down almost 0.4% to 6,242.9 points.

Four shares that have fallen more than most today are listed below. Here’s why they have tumbled lower:

The Ltd (ASX: KGN) share price has fallen a further 11% to $5.21 following the release of its trading update on Tuesday. The ecommerce company’s shares have fallen again despite a broker note out of UBS declaring Kogan’s shares as a buy with a massive $9.55 price target. This price target implies potential upside of over 83% from the current share price.

The Medical Developments International Ltd (ASX: MVP) share price has plunged lower by over 16% to $4.90 after the healthcare company’s U.S. plans for its Penthrox pain management product were dealt a blow. According to today’s release, the U.S. FDA has informed the company that the clinical program for Penthrox is to be put on hold pending a letter outlining outstanding issues and concerns. This letter could take upwards of two months to be received and management will update the market when further information is provided.

The Treasury Wine Estates Ltd (ASX: TWE) share price has dropped 3% to $18.77. Investors have hit the sell button despite the Australian wine industry reporting strong export growth in FY 2018. According to the industry body, courtesy of the SMH, total Australian wine exports jumped 20% to $2.76 billion in FY 2018. This was partly driven by a 55% jump in exports to China. A total of $1.1 billion worth of wine made its way to China during the period.

The Updater Inc (ASX: UPD) share price is down almost 4.5% to $1.20 after the relocation technology company announced a new business vertical. The market appears unimpressed with its fifth vertical – Local Services. This vertical will offer programmatic communication from local businesses to its users and aims to capture a slice of an estimated US$30 billion to US$40 billion that is spent by local businesses on marketing to U.S households.

The ASX small cap up 285% with no sign of stopping...

One Australian company has developed a state of the art device that's revolutionizing hospitals all over the world. Even better, this device is so profitable that the company rakes in 90% margins. That's a lot of cash. So no wonder the stock's up 285% since 2008 – with no signs of stopping...

To discover the name and code, simply click the link below. You'll discover our expert's #1 medical technology pick... and you can decide for yourself whether to get invested today.

Click here to claim your free report.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia has recommended ltd and Treasury Wine Estates Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The 5 mining stocks we’re recommending in 2019…

For decades, Australian mining companies have minted money for individual investors like you and me. But if you believe the pundits and talking heads on TV, those days are long gone. Finito! Behind us forever…

We say nothing could be further from the truth. To earn the really massive returns, you’ve got to fish where others aren’t fishing—and the mining sector could be primed for a resurgence. That’s why top Motley Fool analysts just revealed their exciting new research on 5 ASX miners they believe could help you profit in 2019 and beyond…


The best way we see to play the global zinc shortage… Our #1 favourite large-cap miner (hint: it’s not BHP)… one early-stage gold miner we think could hit the motherlode… Plus two more surprising companies you probably haven’t heard of yet!

For free access to our brand-new research, simply click here or the link below. But be warned, this research is available free for a limited time only, and we reserve the right to withdraw it at any time.

Click here for your FREE report!